William Gillanders, MD

Surgeon

Primary Academic Title

Professor and Vice-Chair, Department of Surgery, Division of General Surgery, Section of Surgical Oncology, Washington University School of Medicine

Clinical Expertise

As a member of our thyroid and breast cancer specialist teams, Dr. Gillanders cares for patients diagnosed with these cancers through treatment and recovery.

Research Interest

Translational research in cancer immunotherapy; neoantigen cancer vaccine development

Education

1991: MD, Duke University, Durham, N.C.
2005: MSCR, Medical University of South Carolina, Charleston

Training

1991 - 1993: Resident, general surgery, Washington University, St. Louis
1993 - 1996: Research fellow, immunology, Washington University
1996 - 1999: Resident and chief resident, general surgery , Washington University

Board Certification

2000: American Board of Surgery, General Surgery

Selected Research Publications

Computational prediction of MHC anchor locations guides neoantigen identification and prioritization.

Xia H, McMichael J, Becker-Hapak M, [...] Gillanders WE, [...] Griffith M
Sci Immunol 2023

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.

Ademuyiwa FO, Gao F, Street CR, [...] Gillanders WE
NPJ Breast Cancer 2022

Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer.

Cui Zhou D, Jayasinghe RG, Chen S, [...] Gillanders WE, [...] Ding L
Nat Genet 2022

Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer.

Peng H, Li L, Zuo C, [...] Gillanders WE
Front Immunol 2022

Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer.

Peng H, James CA, Cullinan DR, [...] Gillanders WE, [...] Hawkins WG
Clin Cancer Res 2021

Challenges targeting cancer neoantigens in 2021: a systematic literature review.

Chen I, Chen MY, Goedegebuure SP, Gillanders WE
Expert Rev Vaccines 2021

Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.

Brown TC, Sankpal NV, Gillanders WE
Biomolecules 2021

Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion.

Sankpal NV, Brown TC, Fleming TP, [...] Gillanders WE
BMC Cancer 2021

Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy.

Supabphol S, Li L, Goedegebuure SP, Gillanders WE
Expert Opin Investig Drugs 2021

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.

Li L, Zhang X, Wang X, [...] Gillanders WE
Genome Med 2021

Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound.

Chen MY, Gillanders WE
Breast Cancer (Dove Med Press) 2021

Cancer vaccines: shared tumor antigens return to the spotlight.

Li L, Goedegebuure SP, Gillanders W
Signal Transduct Target Ther 2020

View All Publications

Contact Information

Washington University Medical Campus

4921 Parkview Place
Saint Louis, MO 63110

Phone Numbers

Appointments: (314) 747-7222
Toll Free: (800) 600-3606

Request an appointment